器质性室性心动过速绝大多数是折返性机制。
Reentry is the chief mechanism in most cases of ventricular tachycardia with organic heart disease.
确定死亡、持续性室性心动过速、纽约心功能分级增加到II或IV级等负性结果发生率为21%。
Adverse outcomes, defined as death, sustained ventricular tachycardia (VT), and increase in New York Heart Association functional class to grade II or IV, occurred in 21% of patients.
目的：观察导管射频消融治疗室性心动过速的疗效及安全性。
Objective: To investigate the efficacy and safety of catheter radiofrequency ablation for ventricular tachycardia.
方法：应用24小时动态心电图检出短阵室性心动过速患者52例，并对其心电图资料进行回顾性分析。
Methods: The clinical data in 52 patients with burst ventricular tachycardia detected by 24-hour dynamic electrocardiogram were analysed retrospectively.
目的观察静脉注射胺碘酮治疗急性心肌梗死合并室性心动过速的临床疗效及其安全性。
Objective To observe the clinical curative effect and its safety of intravenous injection of amiodarone in treatment of acute myocardial infarction (ami) with ventricular tachycardia (VT).
结论高钾血症致室性心动过速救治关键在于在控制和转复室性心动过速的同时积极降血钾。
Conclusion The key of treatment for hyperkalemia-induced ventricular tachycardia is to control and cardioversion of ventricular tachycardia combined with actively lowering serum potassium.
室性二联律和室性心动过速发作以递降顺序分类，所以总是要观察十次最长的发作。
The episodes of bigeminy and ventricular tachycardia were sorted in descending order so that 10 longest episodes were always reviewed.
室性二联律和室性心动过速发作以递降顺序分类，所以总是要观察十次最长的发作。
The episodes of bigeminy and ventricular tachycardia were sorted in descending order so that 10 longest episodes were always reviewed.
应用推荐